A Y L Lau

Summary

Affiliation: The Chinese University of Hong Kong
Country: China

Publications

  1. doi request reprint Burden of intracranial steno-occlusive lesions on initial computed tomography angiography predicts poor outcome in patients with acute stroke
    Alexander Y Lau
    Prince of Wales Hospital, Shatin, Hong Kong
    Stroke 44:1310-6. 2013
  2. doi request reprint Intravenous alteplase for Chinese patients with stroke and borderline eligibility
    Alexander Y L Lau
    Division of Neurology, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, 9 F, Clinical Sciences Building, Shatin, New Territories, Hong Kong
    J Clin Neurosci 19:1383-6. 2012
  3. doi request reprint Significance of good collateral compensation in symptomatic intracranial atherosclerosis
    Alexander Y L Lau
    Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China
    Cerebrovasc Dis 33:517-24. 2012
  4. ncbi request reprint Refractory bulbar and respiratory dysfunction in a young Chinese woman with seronegative, muscle-specific tyrosine kinase antibody-positive myasthenia gravis: response to cyclophosphamide and rituximab treatment
    A Y L Lau
    Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong
    Hong Kong Med J 17:77-9. 2011
  5. ncbi request reprint An expedited stroke triage pathway: the key to shortening the door-to-needle time in delivery of thrombolysis
    A Y L Lau
    Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong
    Hong Kong Med J 16:455-62. 2010

Detail Information

Publications5

  1. doi request reprint Burden of intracranial steno-occlusive lesions on initial computed tomography angiography predicts poor outcome in patients with acute stroke
    Alexander Y Lau
    Prince of Wales Hospital, Shatin, Hong Kong
    Stroke 44:1310-6. 2013
    ..We aimed to identify features of computed tomography angiography associated with unfavorable outcome...
  2. doi request reprint Intravenous alteplase for Chinese patients with stroke and borderline eligibility
    Alexander Y L Lau
    Division of Neurology, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, 9 F, Clinical Sciences Building, Shatin, New Territories, Hong Kong
    J Clin Neurosci 19:1383-6. 2012
    ..Further studies are warranted...
  3. doi request reprint Significance of good collateral compensation in symptomatic intracranial atherosclerosis
    Alexander Y L Lau
    Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China
    Cerebrovasc Dis 33:517-24. 2012
    ..We aimed to study the associations between antegrade flow across stenosis, collateral flow via leptomeningeal anastomosis, and the neurological outcome and recurrence risk in patients with symptomatic intracranial stenosis...
  4. ncbi request reprint Refractory bulbar and respiratory dysfunction in a young Chinese woman with seronegative, muscle-specific tyrosine kinase antibody-positive myasthenia gravis: response to cyclophosphamide and rituximab treatment
    A Y L Lau
    Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong
    Hong Kong Med J 17:77-9. 2011
    ..She remained symptom-free and assumed full maternal care at 1 year. To the authors' knowledge, this is the first report of a Chinese patient with refractory myasthenia gravis who responded to cyclophosphamide and rituximab...
  5. ncbi request reprint An expedited stroke triage pathway: the key to shortening the door-to-needle time in delivery of thrombolysis
    A Y L Lau
    Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong
    Hong Kong Med J 16:455-62. 2010
    ..To assess time management of stroke thrombolysis triage and functional outcomes in patients receiving recombinant tissue plasminogen activator for hyperacute stroke, and identify bottlenecks in delivery of the treatment...